STOK earnings date and last-quarter result: last quarter beat, P/E -10.23. Updated 2026-07-23.
Stoke Therapeutics (STOK) Research Hub
Stoke Therapeutics (STOK) trades on NASDAQ, US in the Healthcare (Biotechnology) sector. As of 2026-10-26, shares last closed at 25.46 USD (+1.68%), in a range — insufficient history for 200-DMA. Valuation: trailing P/E -10.23, market cap 1.74B. This hub links to the full technical, earnings and options research available for STOK.
Last updated 2026-10-26 · Source: end-of-day prices (adjusted); indicators computed by SniperIQ
| Sector | Healthcare (Biotechnology) |
|---|---|
| Exchange | NASDAQ, US |
| Last close | 25.46 USD (+1.68%) |
| 52-week range | 22.05 USD – 33.94 USD |
| Trend regime | Range |
| 14-day RSI | 55.2 (Bullish) |
| Trailing P/E | -10.23 |
| Market cap | 1.74B |
| Dividend yield | 0.00% |
Available research for STOK
Covered Call on STOK: how it works, illustrative setup around the real 25.46 USD price, max profit/loss, breakeven and when to use it. Educational.
Iron Condor on STOK: how it works, illustrative setup around the real 25.46 USD price, max profit/loss, breakeven and when to use it. Educational.
Protective Put on STOK: how it works, illustrative setup around the real 25.46 USD price, max profit/loss, breakeven and when to use it. Educational.
STOK technical analysis: range, last 25.46 USD, RSI 55.2, 52w range 22.05 USD–33.94 USD, real support/resistance. Updated 2026-10-26.
More on SniperIQ
Frequently asked questions
What sector is STOK in?
Stoke Therapeutics (STOK) is classified under Healthcare (Biotechnology), listed on NASDAQ, US.
Is STOK in an uptrend or downtrend?
As of 2026-10-26, STOK is in a range — insufficient history for 200-DMA. See the full technical research page for support and resistance levels.
What is STOK's trailing P/E ratio?
STOK's trailing P/E is -10.23, with a market cap of 1.74B. See the earnings research page for full valuation detail.